Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark R Albertini

Showing results (11-20 of 61) with videos related to

Pageof 7
Sort By:
Current Opinion in Investigational Drugs (London, England : 2000)|August 7, 2003
Preclinical and clinical development of immunocytokinesPaul M Sondel, Jacquelyn A Hank, Jacek Gan, et al.
Biostatistics (Oxford, England)|October 8, 2013
A conditional predictive p-value to compare a multinomial with an overdispersed multinomial in the analysis of T-cell populationsQinglin Pei, Cindy L Zuleger, Michael D Macklin, et al.
Cancers|October 23, 2012
In Situ Conversion of Melanoma Lesions into Autologous Vaccine by Intratumoral Injections of α-gal GlycolipidsUri Galili, Mark R Albertini, Paul M Sondel, et al.
Case Reports in Gastrointestinal Medicine|November 10, 2025
Endoscopic Ultrasound With Fine Needle Biopsy Confirming a Diagnosis of Immune Checkpoint Inhibitor-Related Type 3 Autoimmune PancreatitisDana Ley, Kusum Sharma, Saqib Walayat, et al.
Melanoma Research|May 29, 2019
Enrichment of melanoma-associated T cells in 6-thioguanine-resistant T cells from metastatic melanoma patientsCindy L Zuleger, Michael A Newton, Xiuyu Ma, et al.
Biorxiv : the Preprint Server for Biology|July 28, 2023
SURROGATE SELECTION OVERSAMPLES EXPANDED T CELL CLONOTYPESPeng Yu, Yumin Lian, Cindy L Zuleger, et al.
Journal of Immunological Methods|December 25, 2010
In vivo 6-thioguanine-resistant T cells from melanoma patients have public TCR and share TCR beta amino acid sequences with melanoma-reactive T cellsCindy L Zuleger, Michael D Macklin, Bret L Bostwick, et al.
Mutation Research. Reviews in Mutation Research|June 11, 2022
Molecular characterization of hypoxanthine guanine phosphoribosyltransferase mutant T cells in human blood: The concept of surrogate selection for immunologically relevant cellsNoah A Kaitz, Cindy L Zuleger, Peng Yu, et al.
Melanoma Research|September 24, 2005
Phase II trial of weekly paclitaxel in patients with advanced melanomaLeslie Walker, Heidi Schalch, David M King, et al.
Pigment Cell & Melanoma Research|October 30, 2023
Neutrophil-to-eosinophil ratio as a biomarker for clinical outcomes in advanced stage melanoma patients treated with anti-PD-1 therapyVincent Pozorski, Yeonhee Park, Yusuf Mohamoud, et al.
Pageof 7

Showing results (11-20 of 61) with videos related to

Sort By:
Pageof 7
Current Opinion in Investigational Drugs (London, England : 2000)|August 7, 2003
Preclinical and clinical development of immunocytokinesPaul M Sondel, Jacquelyn A Hank, Jacek Gan, et al.
Biostatistics (Oxford, England)|October 8, 2013
A conditional predictive p-value to compare a multinomial with an overdispersed multinomial in the analysis of T-cell populationsQinglin Pei, Cindy L Zuleger, Michael D Macklin, et al.
Cancers|October 23, 2012
In Situ Conversion of Melanoma Lesions into Autologous Vaccine by Intratumoral Injections of α-gal GlycolipidsUri Galili, Mark R Albertini, Paul M Sondel, et al.
Case Reports in Gastrointestinal Medicine|November 10, 2025
Endoscopic Ultrasound With Fine Needle Biopsy Confirming a Diagnosis of Immune Checkpoint Inhibitor-Related Type 3 Autoimmune PancreatitisDana Ley, Kusum Sharma, Saqib Walayat, et al.
Melanoma Research|May 29, 2019
Enrichment of melanoma-associated T cells in 6-thioguanine-resistant T cells from metastatic melanoma patientsCindy L Zuleger, Michael A Newton, Xiuyu Ma, et al.
Biorxiv : the Preprint Server for Biology|July 28, 2023
SURROGATE SELECTION OVERSAMPLES EXPANDED T CELL CLONOTYPESPeng Yu, Yumin Lian, Cindy L Zuleger, et al.
Journal of Immunological Methods|December 25, 2010
In vivo 6-thioguanine-resistant T cells from melanoma patients have public TCR and share TCR beta amino acid sequences with melanoma-reactive T cellsCindy L Zuleger, Michael D Macklin, Bret L Bostwick, et al.
Mutation Research. Reviews in Mutation Research|June 11, 2022
Molecular characterization of hypoxanthine guanine phosphoribosyltransferase mutant T cells in human blood: The concept of surrogate selection for immunologically relevant cellsNoah A Kaitz, Cindy L Zuleger, Peng Yu, et al.
Melanoma Research|September 24, 2005
Phase II trial of weekly paclitaxel in patients with advanced melanomaLeslie Walker, Heidi Schalch, David M King, et al.
Pigment Cell & Melanoma Research|October 30, 2023
Neutrophil-to-eosinophil ratio as a biomarker for clinical outcomes in advanced stage melanoma patients treated with anti-PD-1 therapyVincent Pozorski, Yeonhee Park, Yusuf Mohamoud, et al.
Pageof 7